OncoSynergy Receives $300,000 STTR Grant to Develop Novel Oncolytic...

Funding expands immunotherapy pipeline

(PRWeb January 14, 2020)

Read the full story at https://www.prweb.com/releases/oncosynergy_receives_300_000_sttr_grant_to_develop_novel_oncolytic_virus/prweb16820569.htm


This is a companion discussion topic for the original entry at https://www.prweb.com/releases/oncosynergy_receives_300_000_sttr_grant_to_develop_novel_oncolytic_virus/prweb16820569.htm